Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0R9T stock hub

LON/0R9T has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R9Tis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

466.8M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R9T

In the news

Latest news · LON/0R9T

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.7

P25 12.9P50 16.9P75 23.5

Trailing P/E15

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC15

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R9T market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

230

Groups with data

Currency

EUR

Showing 230 of 230 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	France
Country code	UK
Employees	1,400
Enterprise value	EUR 470.7M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	FR0012882389
Last refreshed	2026-05-10
Market cap	EUR 466.8M
Price	EUR 36.15
Price currency	EUR
Rev Per Employee	137,599.71x
Sector	Healthcare
Sic	7372
Symbol	lon/0R9T
Website	https://equasens.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.67%
EV Earnings	15.12x
EV/EBIT	11.98x
EV/EBITDA	11.32x
EV/FCF	15.62x
EV/Sales	2.42x
FCF yield	6.45%
Forward P/E	11.67x
P/B ratio	2.28x
P/E ratio	15x
P/S ratio	2.42x
PE Ratio10 Y	29.96x
PE Ratio3 Y	17.98x
PE Ratio5 Y	20.8x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.97%
EBITDA Margin	19.32%
FCF margin	15.64%
Gross margin	28.46%
Gross Profit	EUR 54.8M
Gross Profit Growth	3.26%
Gross Profit Growth Q	-12.27%
Gross Profit Growth3 Y	-4.23%
Gross Profit Growth5 Y	-0.64%
Net Income	EUR 31.1M
Net Income Growth	-18.69%
Net Income Growth Q	-31.14%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	-9.28%
Net Income Growth5 Y	-2.26%
Pretax Margin	21.47%
Profit Margin	16.15%
Profit Per Employee	EUR 22,229
Profitable Years	1
Roa5y	9.46
ROCE	15.72
Roe5y	23.09
ROIC	15
Roic5y	21.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.54%
Cagr1y	-11.27%
Cagr3y	-18.86%
Cagr5y	-15.75%
Div CAGR10	10.15%
Div CAGR3	6.18%
Div CAGR5	5.86%
EPS Growth	-18.37
EPS Growth Q	-31.06
EPS Growth Years	0
EPS Growth3 Y	-9.24
EPS Growth5 Y	-2.22
FCF Growth	-11.15%
FCF Growth3 Y	-15.72%
FCF Growth5 Y	-2.32%
OCF Growth	-14.99%
OCF Growth Q	786.19%
OCF Growth10 Y	1.86%
OCF Growth3 Y	-13.16%
OCF Growth5 Y	-1.2%
Revenue Growth	3.34x
Revenue Growth Q	8.21x
Revenue Growth Quarters	3x
Revenue Growth Years	0x
Revenue Growth3 Y	0.24x
Revenue Growth5 Y	2.58x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 352.2M
Cash	EUR 37.1M
Current Assets	EUR 140.4M
Current Liabilities	EUR 108.5M
Debt	EUR 33M
Debt EBITDA	EUR 0.81
Debt Equity	EUR 0.16
Debt FCF	EUR 1.1
Equity	EUR 205.1M
Interest Coverage	42.99
Liabilities	EUR 147.1M
Long Term Assets	EUR 211.8M
Long Term Liabilities	EUR 38.6M
Net Cash	EUR 4.1M
Net Cash By Market Cap	EUR 0.88
Net Debt EBITDA	EUR -0.11
Net Debt Equity	EUR -0.02
Net Debt FCF	EUR -0.14
Tangible Book Value	EUR 99.2M
Tangible Book Value Per Share	EUR 6.6
WACC	7.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.29
Net Working Capital	EUR 8.9M
Quick ratio	0.88
Working Capital	EUR 31.7M
Working Capital Turnover	EUR 6.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.23%
Dividend Growth	2.15%
Dividend Growth Years	11%
Dividend per share	EUR 1.08
Dividend Years	19
Dividend Yield	2.99%
Ex Div Date	2025-07-02
Last Dividend	EUR 1.08
Payout Frequency	Annual
Payout Ratio	51.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	71.41%
1Y total return	-11.26%
200-day SMA	42.71
3Y total return	-46.59%
50-day SMA	37.19
50-day SMA vs 200-day SMA	50under200
5Y total return	-57.55%
All Time High	114.4
All Time High Change	-68.4%
All Time High Date	2021-02-08
All Time Low	18.34
All Time Low Change	97.11%
All Time Low Date	2014-01-03
ATR	0.94
Beta	0.59
Ch YTD	-19.58
High	36.6
High52	53.2
High52 Date	2025-08-05
High52ch	-32.05%
Low	36.15
Low52	34
Low52 Date	2026-03-24
Low52ch	6.32%
Ma50ch	-2.78%
Price vs 200-day SMA	-15.36%
RSI	38.93
RSI Monthly	40.46
RSI Weekly	40.08
Sharpe ratio	0.18x
Sortino ratio	0.44
Total Return	3.22%
Tr YTD	-19.58
Tr1m	-8.02%
Tr1w	-3.08%
Tr3m	-7.31%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 38.5M
Operating Income Growth	0.56
Operating Income Growth Q	-24.74
Operating Income Growth3 Y	-8.15
Operating Income Growth5 Y	-2.47
Operating margin	19.97

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,888,130%
Net Borrowing	-16,871,578
Shares Insiders	0.21%
Shares Institutions	7.42%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 30M
Average Volume	453.85x
Bv Per Share	13.11
CAPEX	EUR -9.5M
Ch10y	44.76
Ch1m	-8.02
Ch1w	-3.08
Ch1y	-13.52
Ch3m	-7.31
Ch3y	-49.81
Ch5y	-61.05
Ch6m	-9.96
Change	-2.3%
Change From Open	-1.23
Close	37
Days Gap	-1.08
Depreciation Amortization	-1,266,406.4
Dollar Volume	614.6
Earnings Date	2026-09-28
EBIT	EUR 38.5M
EBITDA	EUR 37.2M
EPS	EUR 2.06
F Score	5
FCF	EUR 30.1M
FCF EV Yield	6.4x
Financing CF	-33,562,542
Fiscal Year End	December
Founded	1,996
Goodwill	89,922,639
Graham Number	29.34945
Graham Upside	-18.81
Income Tax	EUR 8.9M
Investing CF	-12,443,874
Is Primary Listing	0
Last Earnings Date	2026-03-30
Last Report Date	2025-06-30
Last Split Date	2015-08-05
Last Split Type	Forward
Lynch Fair Value	EUR 12.05
Lynch Upside	-66.66
Ma150	40.4
Ma150ch	-10.51%
Ma20	39.23
Ma20ch	-7.84%
Net CF	-6,355,230
Next Earnings Date	2026-09-28
Open	36.6
P FCF Ratio	15.49
P OCF Ratio	11.77
Payment Date	2025-07-04
Position In Range	0
Ppne	24,961,354.4
Price Date	2026-05-08
Price EBITDA	EUR 12.54
Ptbv Ratio	4.7
Relative Volume	0.04x
Revenue	192,639,597x
SBC By Revenue	0.07x
Share Based Comp	127,722
Tax By Revenue	4.65x
Tax Rate	21.64%
Tr6m	-9.96%
Volume	17
Z Score	3.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0R9T dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.0%

$1.08 annual per share

Payout ratio

+51.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.9%

11 consecutive years of growth

Total shareholder yield

+3.2%

Next ex-dividend date: 2025-07-02

Performance

LON/0R9T stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R9T?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.4%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

LON/0R9T momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.9

Neutral momentum band

Price vs 200-day MA

-15.4%

50/200-day relationship not available

Beta (5Y)

0.59

Less volatile than the market

Sharpe ratio

0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R9T

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R9T stock rating?

lon/0R9T is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R9T analysis?

The full report lives at /stocks/lon/0R9T/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R9T?

The latest report frames lon/0R9T around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R9T page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.